The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations...
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and...

Press Releases

Nov 2 2015
Washington, D.C. (Nov. 2, 2015) – If the Environmental Protection Agency (EPA) does not correct its course in its final rule for the 2014, 2015 and 2016...
Oct 26 2015
Bill would enhance the voice of emerging companies at the SEC Washington, D.C. (October 26, 2015) – Today, the Biotechnology Industry Organization (...
Oct 21 2015
Washington, D.C. (October 21, 2015) – “Over the past twenty years, agriculture biotechnology has become a valuable tool in ensuring the success of...
Oct 8 2015
Washington, D.C. (October 8, 2015) – The Biotechnology Industry Organization (BIO) commends California Governor Jerry Brown for signing critical...
Oct 7 2015
Washington, DC (October 7, 2015) – The fourth annual BIO Patient and Health Advocacy Summit concluded today, bringing together patient advocacy groups,...
Oct 6 2015
Academic researchers in the SPARK network to showcase drug development programs ready for partnering or venture funding Washington, D.C. (October 6, 2015...
Oct 4 2015
Washington, D.C. (October 4, 2015) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement today...
Sep 29 2015
Thought-provoking sessions will highlight the latest trends and insights on policy and business development Washington, D.C. (September 29, 2015) –...
Sep 28 2015
Washington, D.C. (September 28, 2015) – The following statement may be attributed to the Biotechnology Industry Organization (BIO): "It is...

Biotechnology News

Mar 2 2016 - 1:36am
WALTHAM, Mass.--(BUSINESS WIRE)--The new Fisher Chemical gas chromatography headspace-grade solvents can accurately detect the amount of residual solvent produced during manufacturing, providing users with a measure of toxicity.

Mar 2 2016 - 1:36am
BOSTON--(BUSINESS WIRE)--Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated with severe neuromuscular conditions, and exercise-associated muscle cramps, announced today that it will report its financial results for the year ended December 31, 2015 on Tuesday, March 8, 2016 before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m.

Mar 2 2016 - 1:36am
BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics will present at the following investor conferences: Cowen and Company 36th Annual Health Care Conference on March 8; Barclays Global Healthcare Conference on March 16, 2016.

Mar 2 2016 - 1:36am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals today announced that Doug Treco, PhD, President and Chief Executive Officer, will present at the Cowen and Company 36th Annual Health Care Conference on Monday, March 7, 2016 at 3:00 p.m. E.T. The conference is being held at the Boston Marriott Copley Place. About Ra Pharmaceuticals Ra Pharma combines novel insights into innate immunity with leadership in macrocycle technology to transform the lives of patients with life-threatening disorder

Mar 2 2016 - 1:36am
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Gore releases new 7.5-centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface. Gore developed this size in response to physician needs for certain clinical situations.

Mar 2 2016 - 1:36am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--RaNA Therapeutics, a leading biotech developing a new class of revolutionary RNA-targeted medicines, today announced RaNA's CEO, Ronald Renaud, will present a corporate overview at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8, 2016, at 3:00p.m. EST at the Marriott Copley Place in Boston. About RaNA Therapeutics RaNA Therapeutics is a leading biotechnology company committed to the development of next generation RNA-targeted medic

Mar 2 2016 - 1:36am
CHARLESTON, S.C.--(BUSINESS WIRE)--Aeterna Zentaris Reports on Zoptrex™ Development Progress in China

Mar 2 2016 - 1:36am
LOUISVILLE, Ky--(BUSINESS WIRE)--Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces the opening of its new state-of-the-art manufacturing and services facility in Louisville, KY, in the US. The large, 65,800 ft2 (6,113 m2) facility functions as the Group’s central genomics laboratory in North America, focusing on the custom production of DNA and RNA oligonucleotides synthetic gene synthesis, and genomics servic

Mar 2 2016 - 1:36am
LONDON--(BUSINESS WIRE)--Synexus expands global capability and enters US market with acquisition of Research Across America

Mar 2 2016 - 1:36am
LOS ANGELES--(BUSINESS WIRE)--C3 Jian Announces Appointment of Biotech Veteran H. Stewart Parker as New Board Chair.